Careers  |  Sign In  |  Register

Latest in Medical Students

Reuters Health • The Doctor's Channel Daily Newscast

Extended treatment of HCV type 1 beneficial in slow responders

NEW YORK (Reuters Health) – Patients infected with hepatitis C virus (HCV) type 1 who have a slow response to pegylated interferon-alfa and ribavirin can benefit from continuing treatment for up to 72 weeks, a German team reports in an advance release from Clinical Gastroenterology and Hepatology. Dr....

Reuters Health • The Doctor's Channel Daily Newscast

BAL usually unnecessary for diagnosing respiratory failure in cancer patients

NEW YORK (Reuters Health) - In seeking the cause of hypoxemic acute respiratory failure (ARF) in hematology and oncology patients, broncho-alveolar lavage (BAL) adds little information to that obtained by noninvasive tests, a French study has shown. “BAL is no longer the gold standard when managing...

Reuters Health • The Doctor's Channel Daily Newscast

Efavirenz linked to severe vitamin D deficiency

NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir, a UK group reports in a June 25 advance online issue of AIDS. Dr. Frank A. Post at King’s College London School...